LORATADINE TABLETS

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of 3,000 packages of LORATADINE TABLETS, identified by NSN 6505013770448 and PR 7017496460, at a fixed unit price of $20.01 per package, resulting in a total contract value of $60.03. The order was awarded on July 14, 2026, with a required delivery date of July 29, 2026, under FOB destination terms, meaning the contractor assumes all freight costs and risk of loss until the goods are delivered to the designated location at Fort Bragg, North Carolina. The delivery must be shipped via the fastest traceable means, with parcel post explicitly prohibited, and all packaging must include precise labeling with the contract and order numbers, NSN, manufacturer CAGE codes (1LEZO and 3KJG9), NDC codes (NDC00904-7511-61 and NDC51079-0246-20), and a Transportation Control Number (W50YF251530001). The Government conducts inspection and acceptance at the destination, and strict compliance is required with a zero percent variance tolerance on quantity. Invoices must be submitted electronically through WAWF in accordance with DFARS 252.232-7003 and remitted to the Defense Finance and Accounting Service in Columbus, Ohio, under accounting code 97X4930 5CBX 001 2620 S33189. The contract reflects a firm-fixed-price structure typical for DLA supply orders, with no option quantities, modifications, or socioeconomic set-asides identified, and no formal Contracting Officer’s Representative assigned. The procurement is governed by DoD unit of issue standards and medical substitution guidelines tied to rank identifier 01-00904751161 25D0121, ensuring alignment with military medical needs.